Pablo Luis Ortiz-Romero

机构：Research Institute Hospital 12 de Octubre · ORCID：0000-0003-2985-9639

发表论文 442 篇 · 总被引 15034 次 · h-index 56

代表论文

• A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification (2025 · Blood · 被引 23)
• A plasma biomarker panel for detecting early amyloid-β accumulation and its changes in middle-aged cognitively unimpaired individuals at risk for Alzheimer’s disease (2025 · EBioMedicine · 被引 23)
• European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders (2025 · British Journal of Dermatology · 被引 13)
• ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part one: diagnosis and staging (2025 · British Journal of Dermatology · 被引 10)
• Phase II trial of atezolizumab (Anti-PD-L1) in the treatment of relapsed/refractory IIB/IVB mycosis fungoides/Sézary syndrome patients after previous systemic treatment. EORTC-1652-CLTG “PARCT” (2025 · European Journal of Cancer · 被引 9)
• Real-World Pattern-of-Care Analysis of Primary Cutaneous Lymphomas Radiation Therapy Among European Organisation for Research and Treatment of Cancer Members (2024 · International Journal of Radiation Oncology*Biology*Physics · 被引 9)